Join Jay Dexheimer , Head of Business Development – US, at the Clinical Trial Supply Chain Strategy Meeting East Coast 2019 meeting on June 13th in Boston. Jay will lead a roundtable discussion on “Managing ROI in Forecasting Clinical Supplies” Participants will learn about: Various types of forecasting systems along with amount of information / […]read more
Boehringer Ingelheim Pharma has signed an agreement with N-SIDE to start a pilot project using N-SIDE’s risk-based production planning solution, CT-PRO. Boehringer Ingelheim joins other top pharmaceutical companies, such as Sanofi, who have recently partnered with N-SIDE for projects focused on production optimization. The project will evaluate optimization opportunities for the supply chain of two early phase clinical compounds […]read more
The N-SIDE Annual CT-FAST User Group Meeting took place in Parsippany, NJ. Our global customers met together to share experiences, enjoy shared-learning and stay on top of the latest innovation in clinical trial supplies optimization and forecasting! Some highlights of last week discussions : driving change by showing the impact of decisions thanks to simulation […]read more
Join us at the Clinical Trial Supply Forum, in Brussels. On May 20th, Sébastien Coppe, Head of Consulting Group at N-SIDE, will be co-presenting with Didier Basseras, Vice President Clinical Supplies at Sanofi-Aventis : “Evolving from Push to Pull Clinical Supply Chain Management with Early Phase Optimization” The participants will learn how to : Optimize […]read more
Why is visualizing your trial data at portfolio level essential to improve your performance and ensure better planning? Join our session at Clinical Trial Supply Nordics on June 19-20!
Don’t miss the chance to join Sylvia’s Haller session on June 19 at 3:30 pm at the Clinical Trial Supply Nordics Conference in Copenhagen, Denmark! Learn why visualizing your trial data at portfolio level is essential to improve your performance and ensure better planning: Explore the advantages of having a portfolio level view on clinical […]read more